Gero
Gero.ai is a physics-enabled biotechnology company focused on developing therapeutics against chronic diseases and slowing down human aging. They utilize Large Health Models (LHMs) trained on longitudinal real-world human data, which are physics-based and interpretable, to predict health outcomes and discover novel treatments. The company collaborates with leading institutions like Harvard Medical School and has a scientific approach grounded in complex dynamic systems and deep neural networks. Gero.ai aims to hack aging by understanding, measuring, and controlling its progression, with a mission to cure root causes of chronic diseases. They have also established a collaboration with Pfizer to discover potential targets for fibrotic diseases.
Gero
Gero.ai is a physics-enabled biotechnology company focused on developing therapeutics against chronic diseases and slowing down human aging. They utilize Large Health Models (LHMs) trained on longitudinal real-world human data, which are physics-based and interpretable, to predict health outcomes and discover novel treatments. The company collaborates with leading institutions like Harvard Medical School and has a scientific approach grounded in complex dynamic systems and deep neural networks. Gero.ai aims to hack aging by understanding, measuring, and controlling its progression, with a mission to cure root causes of chronic diseases. They have also established a collaboration with Pfizer to discover potential targets for fibrotic diseases.